Yoshikazu Yonemitsu

R&D Laboratory For Innovative Biotherapeutics
Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Novel NK cell-like phenotype expressing CCR5 and its ligands elicits tumor-specific acquired immunity to carcinomatous peritonitis via host NK-derived IFN-γ.

Novel NK cell-like phenotype expressing CCR5 and its ligands elicits tumor-specific acquired immunity to carcinomatous peritonitis via host NK-derived IFN-γ.

Journal: Journal for immunotherapy of cancer

Published: March 30, 2026

Current development and challenges of NK cell-based immunotherapy for gastrointestinal cancers.

Current development and challenges of NK cell-based immunotherapy for gastrointestinal cancers.

Journal: International journal of clinical oncology

Published: October 23, 2025

Protocol for generation of transmitochondrial cybrids under pyruvate/uridine-supplemented conditions using a microfluidic device.

Protocol for generation of transmitochondrial cybrids under pyruvate/uridine-supplemented conditions using a microfluidic device.

Journal: STAR protocols

Published: January 16, 2025

Generation of transmitochondrial cybrids using a microfluidic device.

Generation of transmitochondrial cybrids using a microfluidic device.

Journal: Experimental cell research

Published: March 19, 2022

Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*.

Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*.

Journal: Chembiochem : a European journal of chemical biology

Published: August 18, 2020

Highly Activated Ex Vivo-expanded Natural Killer Cells in Patients With Solid Tumors in a Phase I/IIa Clinical Study.

Highly Activated Ex Vivo-expanded Natural Killer Cells in Patients With Solid Tumors in a Phase I/IIa Clinical Study.

Journal: Anticancer research

Published: August 02, 2020

The evolution of surgical treatment for gastrointestinal cancers.

The evolution of surgical treatment for gastrointestinal cancers.

Journal: International journal of clinical oncology

Published: June 16, 2019

miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.

miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.

Journal: Anticancer research

Published: August 21, 2018

Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression.

Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression.

Journal: Biochemical and biophysical research communications

Published: July 05, 2018

Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virus.

Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virus.

Journal: Head & neck

Published: March 28, 2018

Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells.

Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells.

Journal: Oncotarget

Published: October 31, 2017

Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma.

Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma.

Journal: Journal of pediatric surgery

Published: June 14, 2017

Showing 1-12 of 40

Last Updated: 09/26/2026